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ABSTRACT: Parkinson’s disease is a neurodegenera-
tive disorder classically characterized by motor symptoms.
Among them, hypomimia affects facial expressiveness and
social communication and has a highly negative impact
on patients’ and relatives’ quality of life. Patients also
frequently experience nonmotor symptoms, including
emotional-processing impairments, leading to difficulty in
recognizing emotions from faces. Aside from its theoretical
importance, understanding the disruption of facial emotion
recognition in PD is crucial for improving quality of life for
both patients and caregivers, as this impairment is associ-
ated with heightened interpersonal difficulties. However,
studies assessing abilities in recognizing facial emotions in
PD still report contradictory outcomes. The origins of this
inconsistency are unclear, and several questions (regarding
the role of dopamine replacement therapy or the possible
consequences of hypomimia) remain unanswered. We
therefore undertook a fresh review of relevant articles
focusing on facial emotion recognition in PD to deepen cur-
rent understanding of this nonmotor feature, exploring mul-
tiple significant potential confounding factors, both clinical
and methodological, and discussing probable pathophysio-
logical mechanisms. This led us to examine recent pro-
posals about the role of basal ganglia-based circuits in
emotion and to consider the involvement of facial mimicry
in this deficit from the perspective of embodied simulation
theory. We believe our findings will inform clinical practice
and increase fundamental knowledge, particularly in
relation to potential embodied emotion impairment in PD.
VC 2018 The Authors. Movement Disorders published by
Wiley Periodicals, Inc. on behalf of International Parkinson
and Movement Disorder Society.
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The original description characterizing Parkinson’s
disease (PD) by motor symptoms1,2 has been updated
because patients also experience cognitive and psychiat-
ric symptoms,3-7 including emotional impairments.
These lead to difficulties in describing bodily sensations,
physiological arousal and feelings, expressing emotions,
and identifying others’ emotions from prosody and
facial expression.8-10 Facial emotion recognition (FER)
is one of the most basic aspects of emotional function-
ing and one of the most critical components of social
behaviors. Aside from its theoretical importance, under-
standing FER disruption in PD is crucial for improving
quality of life for both patients and caregivers. How-
ever, studies assessing FER in PD still report contradic-
tory results. Although 2 reviews and 1 meta-analysis
revealed an FER deficit in PD and outlined potential
biasing factors,9,11,12 the origins of this inconsistency
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are unclear, and several questions remain unanswered.
For instance, what is the actual effect of dopaminergic
medication on FER in PD? Does hypomimia affect FER
in accordance with embodied simulation theory? From
a more methodological perspective, are the tasks cur-
rently used sensitive enough to reveal impairments
among patients? In short, we know that FER is
impaired in PD but do not have sufficient information
to fully understand the underlying mechanisms.
Building on a previous work,9 we therefore under-
took a fresh review of FER in PD to enhance current
understanding of this nonmotor feature while exp-
loring significant potential confounding factors.
Regarding probable pathophysiological mechanisms
subtending impaired FER in PD, we looked at recent
considerations about the role of basal ganglia-based
circuits in emotion. We also reconsidered hypotheses
about embodied simulation that merit further re-
search, despite being mentioned in early studies. We
end by discussing the clinic and social consequences of
emotional dysfunctions in PD.
Methods
We conducted a detailed search of the literature to
extend previous reviews.9,11,12 We searched PubMed
and Web of Science services with the following key
words: Parkinson’s disease, emotion recognition, facial
expression, and decoding. We also hand-searched rele-
vant journals and examined the references of retrieved
articles. Articles were restricted to the English lan-
guage and published between January 1983 and July
2016. This yielded 167 eligible articles. Some publica-
tions were excluded (eg, reviews, studies related to
deep-brain stimulation, articles focused on emotion
production/experience). A total of 59 articles reporting
97 comparisons between PD patients and healthy con-
trols (HCs) during FER tasks were included. For each
experiment, we checked whether significant differences
between patients and HCs were highlighted and
whether the presence of an emotion-specific deficit
was investigated. We also looked at which errors were
made by participants during the experiment to charac-
terize the deficit in detail. Subsequently, we considered
the impact of multiple confounding factors. We did
not attempt to provide an exhaustive report on the
substantial differences across experiments enrolling
heterogeneous samples, which may explain inconsis-
tent results but make comparisons across studies well
nigh impossible. Rather, we discussed the factors that
may play a role in FER impairment in PD and should
be taken into account in future studies.
Facial Emotion Recognition in PD
Overview of Performances
Table 1 provides an overview of the reviewed stud-
ies. For each experiment, it indicates (1) the FER task
used, (2) whether patients’ performance were signifi-
cantly lower than that of HCs, (3) whether the deficit
TABLE 1. Overview of performance on FER tasks (1 of 3)
Task Deficit Anger Disgust Fear Sadness Surprise Happiness Neutral
Scott et al, 1984a MATCH 1 ? ? ? ? ? ? ?
Beatty et al, 1989 ID 1 1 1 1 1 1 1 1
Blonder et al, 1989 ID 1 1 1 1 1 1 1
Blonder et al, 1989 MATCH 1 ? ? ? ? ? ? ?
Borod et al, 1990 ID 2 2? 2? 2? 2? 2? 2? 2?
Borod et al, 1990 DISCRI 2 2? 2? 2? 2? 2?
Caekebeke et al, 1991b DESCRI 2 2? 2? 2? 2? 2?
Dewick et al, 1991c MATCH 2 2 2 2
Madeley et al, 1995c MATCH 2 2? 2? 2?
Madeley et al, 1995 ID 1 1 1 2 2 2
Haeske-Dewick, 1996c MATCH 2 2? 2? 2?
Jacobs et al, 1995 DISCRI 1 ? ? ? ? ? ? ?
Jacobs et al, 1995 MATCH 2 2 2 2 2 2
Jacobs et al, 1995 IMAG 1 2 1 1 2
Jacobs et al, 1995 DESCRI 1 2 1 1
Breitenstein et al, 1998 (1) ID 2 2 2 2 2 2
Breitenstein et al, 1998 (1) MATCH 2 2 2 2 2 2
Breitenstein et al, 1998 (1) DISCRI 2 2 2 2 2 2
Breitenstein et al, 1998 (1) NAME 2 2 2 2 2 2
Breitenstein et al, 1998 (2) ID 1 1 1 1 1 1
Breitenstein et al, 1998 (2) MATCH 1 1 1 1 1 1
Breitenstein et al, 1998 (2) DISCRI 1 1 1 1 1 1
Breitenstein et al, 1998 (2) NAME 1 1 1 1 1 1
Adolphs et al, 1998 INT 2 2 2 2 2 2 2 2
(Continued)
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TABLE 1. Continued
Task Deficit Anger Disgust Fear Sadness Surprise Happiness Neutral
St Clair et al, 1998 ID 2 ? ? ? ? ? ? ?
Kan et al, 2002 ID 1 2 1 1 2 2
Tessitore et al, 2002 MATCH 2 2? 2?
Yip et al, 2003 (1) ID 1 1? 1? 1? 1? 1? 1?
Yip et al, 2003 (1) DISCRI 2 2? 2? 2? 2? 2? 2?
Yip et al, 2003 (2) ID 1 1? 1? 1? 1? 1? 1?
Yip et al, 2003 (2) DISCRI 1 1? 1? 1? 1? 1? 1?
Sprengelmeyer et al, 2003 (1) ID 1 1 1 1 1 2 2
Sprengelmeyer et al, 2003 (1) HEXA 1 1 2 1 2 2 2
Sprengelmeyer et al, 2003 (2) ID 1 1 1 1 2 2
Sprengelmeyer et al, 2003 (2) HEXA 2 2 2 2 2 2 2
Dujardin et al, 2004 (1) ID 1 1 1 1
Dujardin et al, 2004 (2) INT 1 1 1 1
Yoshimura et al, 2005 SCREEN 2 2? 2? 2?
Pell and Leonard, 2005 ID 2 2 2 2 2 2
Pell and Leonard, 2005 DISCRI 2 ? ? ? ? ? ? ?
Pell & Leonard, 2005 (1) ID 2 2 2 2 2 2
Pell & Leonard, 2005 (2) INT 1 1 2 1 2 2
Suzuki et al, 2006 ID 2 2 2 2 2 2 2
Suzuki et al, 2006 HEXA 2 2 2 2 2 2 2
Suzuki et al, 2006d INT 1 2 1 2 2 2 2
Lachenal-Chevallet et al, 2006 ID 1 2 1 1 2
Lawrence et al, 2007 ID 1 1 2 2 2 2 2
Ariatti et al, 2008 ID 1 2 2 1 1 2
Ariatti et al, 2008 MATCH 1 1? 1? 1? 1? 1?
Clark et al, 2008 ID 1 1 2 2 2 1 2 2
Martins et al, 2008 ID 1 1 1 2 2 2
Delaveau et al, 2009e MATCH 2 2 2
Ibarretxe-Bilbao et al, 2009 ID 1 1 1 1 1 1 2
Assogna et al, 2010 ID 1 2 1 2 2 2 2 1
Cohen et al, 2010 ID 2 2? 2? 2? 2? 2?
Paulmann and Pell, 2010f ID 1 1 1 1 1 1 1 1
Clark et al, 2010 ID 1 1 2 2 2 1 2 2
Martinez-Corral et al, 2010 (1) ID 2 2? 2? 2? 2? 2? 2?
Martinez-Corral et al, 2010 (2) ID 1 2 2 1 1 2 2
Narme et al, 2011 ID 1 1 2 1 2 2
Herrera et al, 2011 ID 1 1? 1? 1? 1? 1? 1?
Wieser et al, 2012 ID 2 2 2 2 2 2
Baggio et al, 2012 ID 1 1 1 1 1 2 2
Buxton et al, 2012g ID 1 2 1 2 1 1 1 2
Ventura et al, 2012h ID 2 2 2 2 2 2 2 2
Ventura et al, 2012h DISCRI 2 2? 2? 2? 2? 2?
Ventura et al, 2012h MATCH 2 2? 2? 2? 2? 2?
Garcia-Rodriguez et al, 2012 (1) ID 2 2? 2? 2? 2? 2? 2?
Garcia-Rodriguez et al, 2012 (2) ID 1 1? 1? 1? 1? 1? 1?
Saenz et al, 2013 ID 1 1 1 2
Narme et al, 2013 ID 1 2 2 1 1 2 1
Alonso-Recio et al, 2013 ID 1 1 1 1 1 1
Alonso-Recio et al, 2013 DISCRI 2 2? 2? 2? 2? 2?
Hipp et al, 2014 ID 1 2 2 1 2 2 2
Alonso-Recio et al, 2014a DISCRI 1 1? 1? 1? 1? 1?
Alonso-Recio et al, 2014b (1) ID 1 1 1 1 1 1
Alonso-Recio et al, 2014b (2) DISCRI 1 1 1 1 1 1
Marneweck and Hammond, 2014i DISCRI 1 1
Marneweck et al, 2014 (1) DISCRI 1 1 1 1 1
Marneweck et al, 2014 (2) DISCRI 1 1 1 1 1
Marneweck et al, 2014 (3) DISCRI 1 1? 1? 1? 1? 1? 1?
Marneweck et al, 2014 (4) ID 1 1? 1? 1? 1? 1? 1?
Wabnegger et al, 2015 (1) ID 2 2 2 2 2
Wabnegger et al, 2015 (2) INT 1 2 2 1 1
Laskowska et al, 2015j EIS-F 1 1? 1? 1? 1? 1? 1?
(Continued)
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TABLE 1. Continued
Task Deficit Anger Disgust Fear Sadness Surprise Happiness Neutral
Enrici et al, 2015 ID 1 1 1 1 1 1 1
McIntosh et al, 2015 ID 1 2 1 1 2 2 2 1
Ricciardi et al, 2015 ID 1 2 2 2 2 1 2
Ille et al, 2016 (1) ID 2 2 2 2
Ille et al, 2016 (2) INT 1 2 2 1
Pietschnig et al, 2016 ID 1 2 2 2 2 2
Albuquerque et al, 2016 ID 2 2 2 2 2 2 2 2
Albuquerque et al, 2016 DISCRI 2 2 2 2 2 2 2 2
Wagenbreth et al, 2016 ID 1 1 1 1 2
Lin et al, 2016 (1) ID 1 2 2 1 2
Lin et al, 2016 (2) ID 1 1 2 1 1
Argaud et al, 2016k ID 1 2 1 1
Quantitative summary: n5 97 64% 44% 47% 54% 51% 30% 27% 42%
Task: type of task used by the authors (see Table 2 for details). Deficit: “was the performance of patients with PD significantly lower than that of healthy con-
trols?” A plus sign in a dark-shaded box indicates “yes, a facial emotion recognition deficit was highlighted according to a global score” (ie, whatever the dis-
played emotion). A minus sign in a white box indicates “no, there was no group difference.” When the authors investigated the groups’ performance as a
function of the displayed emotion, the same symbols are used in the boxes corresponding to the specific emotions: a plus sign in a dark-shaded box indicates
that the deficit affected this specific emotion, whereas a minus sign in a white box indicates that recognition of this specific emotion was spared. On the con-
trary, when the authors only examined the groups’ performance according to an overall score encompassing all the emotions, these signs are followed by a
question mark. Question marks on their own mean that no information is available about the emotions displayed in the study. When the box relating to a spe-
cific emotion is empty, it means that the latter was not manipulated in the experiment. Quantitative summary: the percentage of the experiments we reviewed
(n 5 97) that highlighted a facial emotion recognition deficit in PD (general or specific) is indicated in the “Deficit” column. Likewise, for each specific emotion,
we indicate the percentage of experiments that specifically showed that the emotion recognition deficit affected that emotion in particular (ie, when the authors
submitted this emotion to the participant and examined the performance of recognition according to this emotion).
aIn Scott et al (1984), participants were required first to describe a target facial emotion, then to match it with an affective sentence.
bCaekebe et al (1991) also exposed participants to contempt (no group difference).
cIn Dewick et al (1991), Madeley et al.(1995), and Haeske-Dewick (1996), participants were required to choose which facial expression in a pair of photographs
of the same person’s face expressing different emotions matched a printed label. Breitenstein et al (1998) assessed FER among patients who met the criteria
for (1) stage I or (2) stage II PD according to the Hoehn and Yahr classification system. Yip et al (2003) assessed FER (1) among patients with right-sided PD
classified as stage I or II according to Hoehn and Yahr staging and (2) among patients with bilateral PD classified as stages II-V. Sprengelmeyer et al (2003)
assessed FER (1) among patients in the early stages of the disease (mean score 6 SD, 1.7 6 0.5 on the Hoehn and Yahr scale) who had not yet received dopa-
minergic medication and (2) among patients in the more advanced stages (mean score 6 SD, 2.6 6 0.9 on the Hoehn and Yahr scale) under dopamine replace-
ment therapy. Dujardin et al (2004) used a facial emotion rating task. The authors analyzed participants’ performance (1) in terms of the percentage of
accurately identified expressions, where an expression was deemed to have been accurately identified if the emotion scale eliciting the highest intensity rating
corresponded to the target emotion and (2) according to intensity scores. Pell and Leonard (2005) also used a facial emotion rating task. The authors investi-
gated participants’ performance based on both (1) intensity ratings and (2) correlations between the intensity ratings that each patient assigned to a target
face and the set of mean ratings assigned to that stimulus by HCs. This latter method did not allow the authors to run direct comparisons between groups
but still highlighted deviations from normal patterns of sensitivity among patients for specific emotions.
dSuzuki et al (2006) highlighted a specific FER deficit for disgust in PD during a facial emotion rating task, using a refined assessment method based on item
response theory.
eDelaveau et al (2009) conducted a study in which patients with PD and HCs were scanned both with and without levodopa medication. Regarding accuracy
(correct responses), there were no differences between the groups (patients versus controls) or between pharmacological states (levodopa versus placebo)
within these groups. The same data are presented in Delaveau et al (2010).
fPaulmann and Pell (2010) highlighted a negative impact of PD on the recognition of emotions conveyed through different channels (lexical semantic/prosody/
facial expressions), either in isolation (unimodal) or in various combinations (bi- or multimodal emotion cues), with no significant effect of the communication
channel. Martinez-Corral et al (2010) assessed FER among patients with PD (1) without and (2) with apathy.
gBuxton et al (2012) examined FER abilities at 3 levels of difficulty (easy, moderate, and difficult). The authors highlighted deficits in the recognition of facial
expressions of happiness at the moderate and difficult levels, disgust and surprise at the moderate level only, and sadness at the difficult level only. Patients
had no difficulty identifying prototypical facial emotions (easy level).
hVentura et al (2012) analyzed participants’ performance on an identification task and a discrimination task, based on a single composite score. In Garcia-
Rodriguez et al (2012), the FER abilities of de novo patients with PD were tested under 2 conditions: (1) a simple identification task and (2) the same identifica-
tion task concurrent with a secondary task (the Corsi Blocks tapping). Alonso-Recio et al (2014a) assessed FER abilities in PD during a one-back procedure:
participants were required to indicate whether the current stimulus matched the one shown from one step earlier in a sequenced presentation of stimuli. They
highlighted a deficit among the patients that was more pronounced in patients with higher disease severity according to the CISI-PD scale. In another study,
Alonso-Recio et al (2014b) adapted a Stroop task to assess FER in PD taking into account inhibition abilities with an emotional version (ie, participants were
required to identify the emotion portrayed on the presented face while ignoring the incongruent or congruent superimposed emotion category name) and a
nonemotional version (traditional color-word Stroop task). They showed that patients were impaired in the emotional Stroop task but not in the traditional
Stroop task; Likewise, to take into account the visual search abilities, the authors adapted the “face in the crowd” test with an emotional (ie, participants were
required to decide whether the 24 faces showed the same emotion or whether any displayed a different one) and a nonemotional version. Here again, they
showed that PD patients were impaired in the emotional version of the task but not in the classic version, the nonemotional task.
iMarneweck and Hammond (2014) used 2 FER tasks in which participants were required to discriminate between neutral and angry faces. In one, they had to
indicate whether the face expressed anger or neutrality by clicking the appropriate button. In the other, angry and neutral faces appeared successively on the
screen, and participants were required to indicate the interval (first or second) containing the angry face. In both cases, the patients’ performance was lower
than that of HCs. Marneweck et al (2014) used discrimination tasks in which participants were required to discriminate between (1) facial emotions and neutral
faces, (2) facial expressions of the same emotion at different levels of intensity, and (3) 2 facial expressions of the same emotion and a different one.
Wabnegger et al (2015) and Ille et al (2016) used a facial emotion rating task. They assessed participants’ performance (1) according to an index reflecting the
response accuracy and (2) based on intensity ratings of the target emotion only.
jLaskowska et al (2015) chose to use the Emotional Intelligence Scale-Faces (EIS-F), a more ecologically valid task featuring a mixture of basic and complex
emotions (eg, tenderness, admiration, pride, disappointment, feeling of superiority, etc.). The authors based their analyses on signal detection theory, measur-
ing decision-making strategy (response bias) and accuracy of stimulus detection (sensitivity) to determine whether the FER deficit in PD results from a
decision-making impairment or from impaired sensory processes. In Lin et al (2016), 2 groups of patients were required to identify the valence (positive versus
negative) of facial expressions: (1) patients with low motor dysfunction (<35 on UPDRS III; mean, 24; SD, mean, 48.73; SD, 14.58).
kAs in Dujardin et al. (2004), Argaud et al (2016) used a facial emotion rating task and analyzed participants’ performance in terms of decoding accuracy, con-
sidering an expression to be accurately identified if the emotion scale receiving the highest intensity rating corresponded to the target emotion.
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depended on the emotion, and (4) quantitative informa-
tion about the number of experiments highlighting an
FER deficit in PD for both overall performance and each
specific emotion. Table 2 shows the different task types
identified and which aspects of FER in PD are subject to a
deficit. The quantitative summary in Table 1 should be
considered with care, given that percentage rates reflecting
the presence of a deficit for each emotion are based on the
number of experiments in which authors examined FER
as a function of the emotion displayed, when participants
were exposed to that expression. Moreover, it is based on
a qualitative review. See Gray and Tickle-Degnen12 for an
estimation of the deficit magnitude.
Impaired or Intact FER?
Although a nonnegligible number of authors failed
to find any difference between patients and HCs, most
of the studies investigating FER in PD highlighted
lower performance among patients (Table 1). This is
congruent with the meta-analysis by Gray and Tickle-
Degnen.12 Two years earlier, Clark and collabora-
tors13 also underlined the deleterious impact of this
deficit on patients’ social relationships, highlighting a
negative correlation between their FER difficulties and
their level of interpersonal distress.
Is the Deficit Specific or General?
It is quite difficult to know if PD selectively impairs
the recognition of specific emotions or leads to an
overall deficit. Indeed, about 30% of the reviewed
studies did not examine its effect on the recognition of
specific emotions but calculated an overall score
encompassing all the displayed emotions.4,14-29 More-
over, authors did not manipulate the same set of stim-
uli, and some only used a small subset.23,30-35 At last,
some authors who explicitly investigated the recog-
nition of specific emotions showed that although
recognition was impaired for all the emotions they
tested, some were more poorly recognized than
others.24,32,34,36-39 Like Gray and Tickle-Degnen,12 we
noted that FER deficit in PD affected all the basic
emotions but was greater for negative emotions (64%
of studies highlighted a global deficit, 44% for anger,
27% for happiness; Table 1). This could echo the sub-
cortical pathway involving the pulvinar, the amygdala,
and the striatum, which may lead to a coarse but fast
visual information processing.40,41 Indeed, because of
its evolutionary relevance, this preserved route may
induce a preattentive and autonomic bias toward
threatening stimuli like angry faces.42,43 However,
experimental data failed to fully support this “angry
faces advantage” (whereby angry faces are detected
more quickly than others). Some even supported the
TABLE 2. Description of the different types of tasks used in the literature and their conclusions regarding the presence of
an FER deficit in PD
Task Instructions n Deficit
ID Identification task Participants were required to select the appropriate label for a given
emotional expression.
53 39
DISCRI Discrimination task Participants were required to determine whether the faces displayed
simultaneously expressed the same or a different emotion.
16 9
MATCH Matching task Participants were required to match a target facial expression with another facial
expression and/or an affective prosodic sentence expressing the same emotion.
12 4
NAME Naming task Participants were required to name the emotion displayed by the facial expression. 2 1
IMAG Imagery task Participants were required to imagine a target facial emotion and to answer
yes/no questions about the physical characteristics of that expression
(eg, “Are the eyebrows drawn together?”).
1 1
DESCRI Description task Participants were required to answer yes/no questions about the physical
characteristics of a displayed facial emotion (this task was designed
as a perceptual control task for the imagery task).
2 1
INT Intensity rating task Participants were required to assess the emotions portrayed and their intensity
on visual analog scales ranging from “not at all” (ie, emotion absent from
the expression) to “intensively expressed”.
6 5
HEXA Emotion hexagon task The emotion hexagon task is an identification task using morphed facial
expressions that combines 2 closely related emotions (ie, the stimuli are morphed
across a continua that lies around a hexagon: happiness-surprise-fear-sadness-
disgust-anger-happiness).
3 1
SCREEN Screening task Participants were required to press a button as soon as they perceived
a target facial emotion.
1 0
EIS-F Emotional Intelligence
Scale- Faces
Participants were required to indicate which emotions were expressed by a
given facial expression and which were not, choosing between “shown”, “not shown”
and, as a last resort, “hard to say”.
1 1
n: Number of studies that used this type of task out of a total of 97 reviewed experiments; Deficit: studies using the corresponding type of task highlighted a
FER deficit in PD according to a global score.
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reverse “happy faces advantage”44 (see Ceiling Effect
and Task Sensitivity section). In addition, there are
several important caveats. First, these results were
based on the subset of studies reporting participants’
performance as a function of emotion. Second, Gray
and Tickle-Degnen12 chose to pool data across modal-
ities (face/voice). Third, we should bear in mind the
greater diversity of negative as opposed to positive
emotions in the literature. Surprise is ambiguous
(pleasant, unpleasant, astonishment). Classifying it as
a positive emotion is difficult without context. There-
fore, of the 6 so-called basic emotions, there is only 1
prototypical and easily recognizable positive. Hence,
the negative-emotion-specific FER deficit in PD is not
so obvious. Future studies should shed light on this
point by using a larger set of emotions including more
than one positive affect.
What About the Errors Made?
Some authors conducted a deeper investigation of
FER deficit in PD by examining the errors made. In an
identification task, for instance, participants made an
error if they did not select the appropriate label for a
given expression. Instead of just counting this item as
a misidentified expression, it can be quite more inter-
esting to go further and examine the erroneous label.
Did participants make an aberrant error (happiness
versus sadness) or instead confuse 2 closely related
emotions (surprise versus fear)? Only 5 studies
reported this information.23,30,45-47 Three of
them23,46,47 simply stated that patients and HCs made
the same kind of errors. The two others30,45 statisti-
cally confirmed the presence of similar confusion pat-
terns in PD patients and HCs. In Assogna et al,45
patients mixed up negative emotions and assigned a
neutral state to expressions they failed to recognize. In
Argaud et al,30 the most confusing emotion whatever
the group was surprise.
Discrepancies in Results
Several confounding factors have been put forward
to explain discrepancies in results. Some concern
methodological aspects (study design, group size,
instructions), stimuli (intensity, dynamism, emotion),
task type and sensitivity, and analyses (categorical
analyses based on rates of correct answers, continuous
analyses based on intensity ratings, effect of emotion,
covariables). Others could be linked to participants’
sociodemographic features (age, sex, personality) and/
or patients’ clinical characteristics (disease severity,
nonmotor symptoms, medication). In the following
sections, we review evidence for the potential role of
some of the most relevant factors when studying FER
in PD.
Methodological Aspects
Stimuli
Although we are usually exposed to dynamic expres-
sions in real-life situations, very few studies investigat-
ing FER in PD used dynamic stimuli.30,48-50 Because
emotions are defined as transitory changes in several
components of the organism, the dynamism of facial
expressions plays a major role in emotion perception
with a beneficial effect on FER accuracy.51 Moreover,
neuroimaging studies have highlighted differential neu-
ral activity for static versus dynamic facial emotions,
with higher activation in response to dynamic stimuli
in regions processing socioemotional information,
motion and faces and that belong to the mirror neu-
ron system: superior temporal sulcus (STS), visual
area, fusiform gyrus, inferior frontal gyrus, amygdala,
and orbitofrontal cortex (OFC).52-54 However, only
Kan et al48 investigated the effect of stimuli dynamism
on FER in PD. They found that patients’ performance
clearly worsened when they had to recognize emotions
from static rather than dynamic faces and concluded
that this could artificially heighten the impact of PD
on FER. In addition, the stimuli used in FER studies
in PD generally depicted emotions at full-blown inten-
sity. As emotional intensity has been shown to have a
beneficial effect on FER,24,38,45 it is important to take
this factor into account, especially knowing that
patients could lose this positive effect.32
Task Type and Difficulty
Task type variations across studies make consistent
results less likely to emerge. In most cases, authors
used identification tasks that require selecting the
appropriate label for a given emotion. The remainder
frequently chose discrimination/matching tasks that
require judging whether or not 2 faces express the
same emotion (Table 2). This may reflect different
stages in the FER processs.55 Although both involve
intact perceptual information processes occurring rela-
tively early after stimulus onset, identification requires
additional knowledge yielded by a categorization pro-
cess. Thus, task type seems to determine task diffi-
culty, and FER deficit in PD could be associated with
a deficit in early perceptual and/or categorization pro-
cesses. In the literature, identification tasks more fre-
quently highlighted an FER deficit in PD (Table 2).
However, Gray and Tickle-Degnen12 showed a greater
FER deficit during discrimination tasks. Furthermore,
the level of difficulty can vary within the task. The
forced-choice procedure of Cohen et al19 only featured
2 emotional labels, even though participants were
exposed to 5 facial emotions. This considerably
increased the probability of giving a correct answer by
chance and then could explain the absence of a signifi-
cant difference between patients and HCs. Last, the
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above-mentioned problem of using prototypical stim-
uli and the differing levels of difficulty across emotions
could result in a ceiling effect, thus biasing results (see
below).
Ceiling Effect and Task Sensitivity
A lack of task sensitivity may have meant that sig-
nificant differences between patients and HCs went
unnoticed. In some studies, scores were very close to
maximum, which suggests a ceiling effect that would
have concealed any deficit.20,23,31,56,57 This could also
induce a bias in favour of an emotion-specific deficit,
especially when happiness recognition was compared
with that of other emotions. Indeed, happy expres-
sions are recognized more quickly and accurately than
others. This could be related to its most distinctive
configuration with a very salient feature, the smile,
whereas other facial expressions show more overlap-
ping, less distinctive features.58-63 Thus, it is not
suprising that a specific FER deficit for negative emo-
tions emerges, whereas happiness recognition elicits
higher accuracy scores.35,47,48,64-68 One solution to
avoid this biais would be to combine different task
types within the same study15-17,23,24,28,36,37,56,69 or
use more refined assessment methods.22,70 Alterna-
tively, FER could be assessed in more detail using rat-
ing tasks in which participants assess emotions and
quantify their intensity. More specifically, they rate a
target expression on a set of emotional visual
analog scales (VAS). Few studies used rating
tasks,30,32,33,56,70-72 but all except one71 highlighted
an FER deficit among patients. However, when inten-
sity ratings were dichotomized as correct (when the
scale corresponding to the target emotion had the
highest intensity rating) versus incorrect, the deficit
was not always reported.33,72 Surprisingly, only Dujar-
din et al32 analyzed response patterns according to the
intensity scores on each VAS. They showed that
patients rated the target emotion lower than HCs did
and systematically rated surprise higher, whatever the
emotion displayed. Thus, using VAS allows for a
deeper analysis. Although this methodology is still
rare in studies investigating FER in PD, it has been
successfully used to characterize emotional bias in
schizophrenia and depression when no impairment
emerged from categorical judgments based solely on
response accuracy.73,74
Clinical Factors
Patients’ characteristics varied significantly across and
within studies. Some enrolled patients who had recently
been diagnosed and were not yet receiving medication,
patients under dopamine replacement therapy (DRT)
with a more severe disease including nonmotor symptoms,
or patients who had temporarily interrupted their treat-
ment. Thus, disease duration and severity, medication,
cognitive/visuospatial impairments, and mood disorders
are (quite interrelated) factors that could contribute to
FER impairment in PD.
Disease Severity and Facial Hypomimia
Although an FER deficit has been highlighted in the
early stages of the disease,21,32,66,69,70,75 it was greater
in the most severely affected patients.15,28,29,36,38,68,76
That said, when the link between deficit magnitude and
disease severity was investigated with correlations,
results differed. Based on these statistics, Gray and
Tickle-Degnen12 suggested that the level of FER deficit
is unrelated to the level of motor disability reflected by
Hoehn and Yahr staging.77 However, the average
patients included in their meta-analysis exhibited mild
to moderate motor disability. Their conclusions would
have been different in more severe cases. Even when dis-
ease severity was measured with the Unified Parkinson’s
Disease Rating Scale, regarded as more sensitive than
Hoehn and Yahr staging,78,79 results still diverged but
seemed to be in favour of a positive correlation between
disease severity and FER deficit.24,64,65,67,80,81 PD pro-
gression is very heterogeneous and depends on several
factors. Patients with the same disease duration/severity
may have different patterns of neuronal loss in striatal,
limbic, and cortical regions.82,83 Thus, to examine the
link between disease severity and FER deficit in PD, it
might be useful to employ more sensitive markers (neu-
roimaging) of disease progression or subtype.84 Further-
more, FER deficit could also be linked to motor
asymmetries in PD, but the question of whether patients
with left-dominant motor symptoms (LPD) showing rel-
atively greater neural degeneration in the right hemi-
sphere have a more severe deficit than patients with
right-dominant motor symptoms remains open. LPD
patients could be more likely to show FER impairments
considering the relatively greater role of the right hemi-
sphere in FER (at least for anger, fear, and sadness)
and the prominence of visuospatial deficits in LPD
patients.85,86 Last, since the earliest studies, emotional
disorders in PD concern both expression and recogni-
tion, and some authors have even reported positive cor-
relations between facial expression and FER
impairment.17,37,87-89 These findings are in line with a
peripheral component of the FER deficit arising from
facial hypomimia in PD. This assumption is furhtuer
developed in the Discussion section (see New Hypothe-
ses Based on Embodied Simulation section).
Visuospatial Deficits and Other
Cognitive Symptoms
From the earliest studies, authors controlled for
visual functions with tasks such as the Benton Facial
Recognition Test (BFRT).90 Some found FER impair-
ment among patients with no deficit in neutral faces
recognition,15,16,23,29,68,69,76,91 whereas others showed
A R G A U D E T A L
560 Movement Disorders, Vol. 33, No. 4, 2018
that face-processing impairment co-occurs with the
deficit.24,46 Gray and Tickle-Degnen12 did not report
any significant differences in FER abilities between
patients who performed normally on tests like BFRT
and patients with abnormal performance. They con-
cluded that FER deficit in PD exists beyond a general
deficit in face processing. However, the BFRT may not
be sensitive enough to highlight a deficit.38 Based on
more accurate measurements of visuospatial abilities
including low-level visual functions (contrast sensitiv-
ity), some authors suggested that FER deficit could be
related to visuospatial impairments in PD.28,38,47,75,92
For instance, showing that the ability to discriminate
graded intensities of angry faces was positively corre-
lated with the ability to discriminate unperfect/perfect
circles (radial frequency patterns), Marneweck and
Hammon indicated that impaired ability to perceive
visual forms could contribute to FER deficit in PD.38
It is noteworthy that visual and emotional systems are
extensively interconnected; for example, the amygdala
is connected to the superior colliculus via the pulvinar,
to the OFC, and the anterior cingulate cortex, as well
as to cortical visual regions in the temporal cortex.41
Furthermore, the idea that FER deficit in PD could be
secondary to executive dysfunction is an old one.
Working memory impairment could influence FER as the
ability to manage, maintain, and operate with present and
stored information is affected (particularly true for
sequentially presented stimuli29. Likewise, divided and
selective attention is impaired in PD.93 Thus, FER deficit
in PD could be linked to attentional difficulty to process
different sources of information at the same time. As
authors who assessed cognitive abilities used different
tests measuring different aspects of executive function, no
consistent conclusion could be drawn regarding the link
between cognitive impairement and FER in
PD.21,32,36,45,48,56,94 In recent studies,21,22,26,29,45,95 how-
ever, an FER deficit was confirmed among patients after
controlling for cognitive symptoms (including working
memory and attention processes) but seemed to be influ-
enced by their magnitude.
Mood Disorders
As emotional processes are disrupted in depres-
sion96,97 and knowing the high incidence of depression
in PD,7,98 it has been suggested that FER deficit is not
specific to PD but is linked to mood disorders. The
studies we reviewed usually controlled for this aspect
by selecting patients with normal depression scores
and/or directly testing the effect of depression on per-
formance. Here again, results were heterogeneous.
When they compared the performance of relatively
depressed patients with those with normal scores and
assessed correlations between FER performance and
depression score, Gray and Tickle-Degnen12 concluded
that FER deficit is not secondary to depression in PD.
Since 2010, only Baggio et al64 and Linn et al76 have
reported a link between depression and FER in PD.
Concomitant with depression, apathy and anxiety are
also frequent in PD.3,99 However, these mood disor-
ders have been taken into account less often, although
some studies have highlighted their influence on FER
(anxiety: Clark et al13 and Ille et al33; apathy: Robert
et al100 and Martınez-Coral et al25).
Dopamine Replacement Therapy
Some authors who assessed FER in patients who were
not yet receiving medication or had temporarily with-
drawn from DRT highlighted a deficit in the absence of
treatment.32-34,94 Others failed to find any difference
between patients without DRT and HCs.18.,49 Only
Sprengelmeyer et al68 directly compared medicated and
unmedicated patients on FER. They reported a deficit in
patients whatever the treatment condition, but found a
greater one among unmedicated patients. This is consis-
tent with the positive correlation between patients’ per-
formance and daily levodopa-equivalent dose (LED)
found by Assogna et al.45 However, no other authors
who looked for such correlations found this
result.19,28,38,45,64,65,67,75 Otherwise, several studies
have reported a beneficial effect of DRT on FER in PD.
In Tessitore et al,101 both patients with and without
DRT showed reduced amygdalar activation during
angry and fearful faces processing. However, as evi-
denced by increased blood-oxygen-level dependent
(BLOD) responses in the drug-on relative to the drug-
off state, dopamine repletion partially restored the
amygdala response. Similarly, Delaveau et al102
highlighted restoration of default mode network deacti-
vation after levodopa administration in PD (posterior
cingulate and lateral temporal cortices). In HCs,
reduced activation of the mesocorticolimbic regions
involved in emotional processing (with difficulties in
recognizing anger103) followed the administration of a
dopamine antagonist.103,104 Conversely, Delaveau
et al105,106 reported reduced amygdala activity after
levodopa administration in HCs and patients. These
results might appear contradictory, with DRT having a
beneficial effect on FER in some cases and a detrimental
one in others, but it would depend on disease progres-
sion. In the early stages, mesocorticolimbic pathways
would be relatively spared compared with the motor
pathway.82,107 Thus, the dose of levodopa needed to
improve motor symptoms may simultaneously overdose
mesolimbic projections to the amygdala. In more severe
stages, DRT may have a beneficial effect, compensating
for dopamine depletion, and blocking the responses of
mesocorticolimbic structures in HCs by administering
dopamine antagonists may mimic disease progression.
The DRT overdose effect has already been highlighted
in cognitive functions.108 Regarding emotion recogni-
tion, only 1 study specifically examined the impact of
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DRT in early PD109 and found more pronounced diffi-
culty recognizing emotional prosody among early
patients under DRT versus the drug-off condition.
Discussion
A schematic diagram summarizing the review is
shown in Figure 1.
What Can We Learn From This Review?
Recognition of the 6 basic facial emotions is
impaired in PD, but the deficit seems to be greater for
negative emotions. Because of high variability in
results, several potential confounding factors need to
be considered. Although some of them were
highlighted by Assogna et al11 and investigated by
Gray and Tickle-Degnen,12 no reliable conclusions
could be drawn as to the effects of disease severity,
depression, or cognitive/visuospatial symptoms or the
impact of dopaminergic medication. Moreover, neither
anxiety nor apathy was analyzed. Our review indicates
that FER deficit in PD (1) depends on disease severity,
while observable from disease onset; (2) is linked to
visuospatial disturbances, notably low-level visual dys-
function; (3) is more pronounced in patients with cog-
nitive impairment; (4) is not restricted to depression
but seems to increase with the magnitude of mood
disorders including anxiety and apathy; and (5) fluctu-
ates according to DRT, with an overdose effect in the
early stages and a beneficial effect as PD progresses
and treatment compensates for dopamine depletion.
One important aspect underlined is the potential
lack of task sensitivity when assessing FER and other
forms of processing. Some studies that failed to find
behavioral differences nevertheless observed deficits at
the cerebral level.57,72,81,101 Wieser et al81 reported
diminished early visual discrimination of facial emo-
tions among patients at the electrocortical level, but
no differences in affective ratings or recognition accu-
racy. Here, behavioral assessments were not suffi-
ciently sensitive to detect subtle impairments already
present at the neural level. Intensity rating tasks offer
an alternative method for accurately studying FER in
PD. Analyses of response patterns distinguishing bet-
ween target and nontarget VAS allow both FER
accuracy (qualitative information) and emotion dis-
crimination (quantitative information) to be appraised.
So far, however, only Dujardin et al32 have assessed
FER among patients using intensity ratings per se.
They reported a weaker level of emotion discrimina-
tion in PD, leading to noisy responses, with lower rat-
ings on target scales and higher ratings on nontarget
scales. In addition, such more refined methodologies
should be used to avoid a potential ceiling effect. In
the same vein, future studies should use dynamic
FIG. 1. Facial emotion recognition in Parkinson’s disease: review and discussion. (1) level of impairment, (2) emotions-specificity, (3–4) method-
ology, (5-6) underlying pathophysiological mechanisms with (5) recent considerations about basal ganglia-based circuits in emotions, (7) new
hypothesis related to hypomimia, (8–11) potential clinical confounding factors.
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stimuli portraying more subtle/complexe emotions
such as tenderness, disappointment22,34 (with more
than one positive emotion) to investigated the deficit
consequences in conditions closer to everyday reality.
Furthermore, this review encourages future studies
to adopt a precautionary approach as far as possible
avoiding the effects of clinical confounding factors
and/or evaluating their impact on FER. Although it
could increase study duration, patients should undergo
an extensive neuropsychological/psychiatric interview
investigating numerous aspects of cognitive function-
ing and mood-related features. Thus, patients with
mood and/or cognitive disorders could be excluded or
test results could be correlated with FER outcomes.
Likewise, knowing the clear influence of DRT on
FER, future studies should take into account the LED
calculated for each patient according to common
guidelines110 or enrolled patients not receiving medica-
tion yet or assessed off medication. At last, as far as
disease duration/severity is concerned, more sensitive
markers should be privileged. Future studies will
surely favour neuroimaging techniques rather than
only clinical scales that despite scoring symptoms
severity, do not convey much information about dis-
ease progression or subtype.
PD Neuropathology and Amygdalar Syndrome
Neural changes in numerous areas and impaired
dopamine transmission in the mesocorticolimbic path-
way are invoked to explain FER deficit in PD. Indeed,
not only putaminal but also orbitofrontal and amyg-
dalar presynaptic dopaminergic functions were altered
in early PD.111 In addition, brain responses recordings
during FER tasks have revealed decreases in striatal,
amygdalar, and orbitofrontal activity and lower acti-
vation in analytic temporal facial recognition areas
(STS and fusiform gyrus).57,72,101,112 Lotze et al112
have shown that the less dopamine transporter avail-
ability (DAT) present in the putamen, the lower the
ventrolateral prefrontal cortex activation in response
to emotional gestures and highlighted a positive corre-
lation between the putaminal DAT reduction and the
number of errors in emotional gestures recognition.
Similarly, morphometry analyses reported decreased
gray-matter volume in numerous limbic, paralimbic,
and neocortical associative temporo-occipital
areas64,66,113,114 and showed that the atrophy could
be associated with the deficit, as gray-matter volume
in these regions correlated with patients’ FER perfor-
mance.64,66 More specifically, impairment of the
amygdala, observed since the early stages and worsen-
ing with disease progression,107,115,116 has often been
invoked to explain emotional deficiencies in PD, as we
know that the amygdala circuitry is involved in multi-
ple behavioral functions including emotional arousal
and emotion-saliency appraisal.117,118 In their recent
review, Diederich et al119 clearly reported the behav-
ioral consequences of amygdalar dysfunction in PD
and depicted this amygdalar syndrome as both a
“failing doorman” who struggles to identify emotional
contents of sensory inputs and a “failing disk jockey”
who cannot orchestrate emotional outputs adequately
anymore. They also specified that dopamine could
induce hyperactivity of the amygdala, a finding that
fits with the hypothesis of an overdose effect on FER
in early PD and that compensatory mechanisms could
occur as well (see New Hypotheses Based on Embod-
ied Simulation section).
Basal Ganglia-Based Circuits and Emotions
FER deficit in PD could also be discussed in light of
neural synchronizations within and between the basal
ganglia (BG).120 The BG may be involved in emotion
processing in the same way they are in motor and cog-
nitive functions. Cortico-BG-thalamocortical loops
may inhibit nonrelevant information (nontarget emo-
tions/related facial features) and activate relevant ones
(target emotions/related facial features) just as they
select a specific movement by inhibiting competing
programs and disinhibiting the selected one.121 More-
over, BG-based circuits are involved in automated
chunked representations of action/cognitive sequences
and contribute to the suppression of goal-directed
behavioral control when it becomes habitual.122 The
progressive loss of rapid habitual processing and the
replacement of automatic control by effortful process-
ing may make PD patients more vulnerable to interfer-
ence and lead to difficulty in performing even well-
known procedures. The BG may perform similarly
when it comes to processing emotional information
efficiently. Regarding FER, the BG might help to select
and control emotional patterns engrammed in cortical
and subcortical structures (face fusiform area for face
perception, amygdala for relevance detection, OFC for
evaluation-driven emotion processing) by inhibiting
competing patterns and coordinating the whole pro-
cess.120 Studies investigating subthalamic nucleus
deep-brain stimulation in PD suggest that the BG
recruit and synchronize the activity of the face fusi-
form area, amygdala, and OFC.123,124 Dysfunction
within BG-based circuits may therefore introduce
noise into the system, disrupt the synchronization pro-
cess, and lead to biased emotional judgments charac-
terized by a weaker emotion discrimination (noisy
responses) that could be highlighted by rating tasks.
New Hypotheses Based
on Embodied Simulation
The link between facial expression and FER impair-
ment highlighted since the earliest studies on FER in
PD17,37,87 recall embodied simulation theory, sugges-
ting that disturbed motor processing can lead to
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emotion recognition deficiency. According to this the-
ory, emotion recognition is facilitated by internally
generated somatosensory representations triggered by
the simulation of a perceived facial expression that
partially activates the corresponding emotional state in
the observer.55,125-127 This is subtended by
somatosensory-related cortices and could be linked to
facial mimicry, the tendency to replicate others’ facial
expressions.128,129 Hence, in HCs, facial electromyog-
raphy (EMG) could highlight congruent facial muscle
responses to facial expressions, which could foster
emotion recognition.130-132 However, one of the most
frequent and distinctive Parkinsonian motor symptoms
is hypomimia.1 Thus, in addition to central disorders,
emotional symptoms in PD may be induced by periph-
eral dysfunction associated with impaired facial mim-
icry. To our knowledge, only 2 studies tested this
hypothesis.30,133 By recording EMG responses during
an FER task, authors showed that FER impairment
was accompanied by disruption of facial mimicry in
PD. During the experiment, facial expressions were
mimicked as expected, but emotion-specific EMG var-
iations were disturbed among patients with weaker-
than-normal corrugator and medial frontalis reactions
in response to angry and sad faces respectively, and
almost no reactions from the orbicularis and the zygo-
maticus in response to happy faces. These facial reac-
tions could be linked to emotion-decoding accuracy
and response time: the weaker the responses, the
lower the performance was. Neuroimaging and elec-
trophysiological studies bring some very interesting
elements here, suggesting a rearranging of the brain
mechanisms underlying FER in PD.57,72,112,134 Yoshi-
mura et al57 have shown that event-related potential
recordings in response to fearful faces were generated
within the parietal somatosensory cortex among
patients instead of the amygdala and the visual tempo-
ral cortex as in HCs. Similarly, in accordance with
Anders et al,134 who highlighted a ventrolateral pre-
motor cortex compensatory activity during emotions
processing in Parkin mutation carriers, Wabnegger
et al72 showed a stronger activation in somatosensory
regions among patients that was positively correlated
with their recognition performance. The somatosen-
sory recruitment could be considered a compensatory
mechanism following dopamine depletion and/or path-
ological changes in the amygdala, which may over-
come emotional deficits in PD. Finally, those results
raise the question whether facial mimicry and its feed-
back to neural systems are a necessary part of the pro-
cess of recognizing emotion through simulation. An
alternative assumption stipulates that emotion recogni-
tion could only lie on sensorimotor simulation without
measurable facial mimicry.127 In this view, FER
impairment in PD could stem not from a disturbance
of facial mimicry but from incongruent feedback that
comes into conflict with the internal simulation of the
observed facial expression. In any case, facial mimicry
may not be mandatory but could constitute an inter-
esting therapeutic lever to counteract FER deficit in
PD when patients are asked to consciously imitate to
accurately recognize.
Conclusion
Hypomimia has considerable repercussions on
patients’ (often perceived as bored, anxious or
cranky135-137) and relatives’ quality of life, damaging
interpersonal relationships and gradually increasing
social isolation.1,138 Patients, caregivers, and clinicians
can break this vicious cycle. It starts with awareness
of the patients’ difficulties in decoding, expressing,
and mimicking emotions, along with their attendant
social consequences. Research on these issues could
also improve medical management, as therapeutic
strategies can be adapted to patients’ symptoms, espe-
cially knowing that there are several PD subtypes with
3 separate phenotypes: mainly motor/slow progres-
sion, intermediate, and diffuse/malignant.84 Patients
with the latter are more likely to exhibit nonmotor
symptoms, including cognitive and mood disorders,
but patients with the main motor form may also
develop emotional impairments as a consequence of
impaired facial mimicry. Finally, these findings open
up a new line of inquiry into patients’ masked face
and its impact on socioemotional communication
among both patients and their caregivers.
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